CAH
Cardinal Health, Inc.

3,346
Mkt Cap
$62.83B
Volume
156.00
52W High
$230.81
52W Low
$120.72
PE Ratio
32.49
CAH Fundamentals
Price
$225.76
Prev Close
$226.32
Open
$226.56
50D MA
$207.48
Beta
0.32
Avg. Volume
1.74M
EPS (Annual)
$6.45
P/B
-18.47
Rev/Employee
$3.86M
Loading...
Loading...
News
all
press releases
Earnings Winners: 2 Buy Rated Stocks Raising Guidance
The 2025 Q4 earnings season continues to be one of positivity, with several companies, including these two that sport buy ratings, knocking it out of the park and raising their outlooks.
Zacks·16h ago
News Placeholder
More News
News Placeholder
BD Stock Dips in Pre-Market Despite Q1 Earnings Beat, Margins Up
BDX posts an earnings beat with revenue growth and expanding margins in first-quarter fiscal 2026 quarter, though adjusted profit declined year over year.
Zacks·22h ago
News Placeholder
ProShare Advisors LLC Has $173.98 Million Stock Position in Cardinal Health, Inc. $CAH
ProShare Advisors LLC lowered its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 9.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC...
MarketBeat·1d ago
News Placeholder
Cardinal Health (NYSE:CAH) Price Target Raised to $260.00
Evercore ISI boosted their price target on Cardinal Health from $250.00 to $260.00 in a research report on Friday...
MarketBeat·3d ago
News Placeholder
Cardinal Health, Inc. $CAH Position Lessened by Ironwood Investment Counsel LLC
Ironwood Investment Counsel LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 20.4% during the third quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·3d ago
News Placeholder
Cardinal Health, Inc. $CAH Shares Bought by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 7.7% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·3d ago
News Placeholder
Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates
DOCS beats Q3 EPS and revenue estimates, but shares plunge 38.5% after hours as margins contract and FY26 revenue guidance is lowered.
Zacks·4d ago
News Placeholder
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·4d ago
News Placeholder
Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings
DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and consumer testing.
Zacks·4d ago
News Placeholder
Leerink Partners Raises Cardinal Health (NYSE:CAH) Price Target to $268.00
Leerink Partners upped their price objective on Cardinal Health from $240.00 to $268.00 and gave the company an "outperform" rating in a research note on Thursday...
MarketBeat·4d ago
<
1
2
...
>

Latest CAH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.